Daniel Allen's Net Worth

$21.6 Million

Estimate Recalculated Jul 17, 2024 04:00PM EST

Who is Daniel Allen?

Daniel Allen has an estimated net worth of $21.6 Million. This is based on reported shares across multiple companies, which include SharpSpring, Inc., and PharmaCyte Biotech, Inc..

SEC CIK

Daniel Allen's CIK is 0001736605

Past Insider Trading and Trends

2019 was Daniel Allen's most active year for acquiring shares with 4 total transactions. Daniel Allen's most active month to acquire stocks was the month of March. 2019 was Daniel Allen's most active year for disposing of shares, totalling 4 transactions. Daniel Allen's most active month to dispose stocks was the month of May. 2019 saw Daniel Allen paying a total of $0.00 for 1,243,309 shares, this is the most they've acquired in one year. In 2019 Daniel Allen cashed out on 1,763,454 shares for a total of $21,602,311.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SharpSpring, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
585
—
—
585
Jul 24
Form 4
-100.00%
-1.76M
$12.25
-$21,602,311.50
0
Jun 17
Form 4
∞
1.24M
—
—
1.24M
May 9
Form 4
+24.07%
488
—
—
2.52K
Apr 23
Form 4
+42.15%
601
—
—
2.03K
Jan 21
Form 4
+65.05%
562
—
—
1.43K
Oct 17
Form 4
-50.00%
-864.00
—
—
864
Jul 20
Form 4
—
0
—
—
0
Apr 27
Form 3
—
0
—
—
0
No matching records found

PharmaCyte Biotech, Inc. (PMCB) Snapshot price: $2.1702

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 28
Form 3
—
0
—
—
0
No matching records found